Zimmer, Inc. v. Howmedica Osteonics Corp.

111 F. App'x 593
CourtCourt of Appeals for the Federal Circuit
DecidedMay 26, 2004
DocketNo. 03-1428
StatusPublished
Cited by3 cases

This text of 111 F. App'x 593 (Zimmer, Inc. v. Howmedica Osteonics Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zimmer, Inc. v. Howmedica Osteonics Corp., 111 F. App'x 593 (Fed. Cir. 2004).

Opinion

DYK, Circuit Judge.

Zimmer, Inc. (“Zimmer”) appeals the decision of the United States District Court for the Northern District of Indiana denying Zimmer’s motion for summary judgment of infringement of U.S. Patent No. 5,290,313 (the “ ’313 patent”), entitled “Offset Prosthetic Stem Extension,” and granting summary judgment of noninfringement in favor of Howmedica Osteonics Corporation (“Howmedica”). Zimmer, Inc. v. Howmedica Osteonics Corp., 258 F.Supp.2d 874 (N.D.Ind.2003). We reverse and remand.

BACKGROUND

Appellant Zimmer is the assignee of the ’313 patent, which is directed to a modular system for prosthetic joints that are surgically implanted. The system is particularly suitable for use with prosthetic knee joints. Figure 2 of the patent is reproduced below:

[[Image here]]

The system includes a base portion 10 and a stem extension 1 that is inserted into a bone (in the case of a prosthetic knee, the tibia). The base portion includes a base mounting portion 12, and the stem extension includes a stem mounting portion 2 and an elongated stem portion 3, which are joined by a connection portion 4. The base portion is attached to the stem extension by mounting the base mounting portion on the stem mounting portion. In the embodiment shown in Figure 2, an extending pin 33 of the stem mounting portion mates with a corresponding recess 43 of the base mounting portion in a structure known as a “Morse taper.” The axis of the Morse taper A is offset from the axis of the elongated stem portion B by [596]*596offset 0. This permits the elongated stem portion to be inserted into the intermedullary canal (the portion of the bone containing marrow) of the tibia, while the base portion remains centered relative to the resected bone surface (the surface of the bone after a portion of the bone is removed during surgery).

Appellee Howmedica manufactures a modular prosthesis system similar to that disclosed in U.S. Patent No. 5,782,920 (“the ’920 patent”), for which Howmedica is a licensee. Figure 2 of the ’920 patent is reproduced below:

[[Image here]]

Howmedica’s system also includes a base portion 12 that is joined to an elongated stem portion 14. However, the adapter element 16 before assembly is separate from the elongated stem portion, unlike the connection portion in the ’313 patent, and it is attached to the elongated stem portion by a threaded connection. In addition, the base portion is attached to the connection portion by a second threaded connection, rather than the Morse taper disclosed in the ’313 patent.

On June 17, 2002, Zimmer sued Howmedica, alleging that Howmedica’s products infringed claim 1 of the ’313 patent along with claims 2-4, 6, 8, 13, 14, and 17, all of which are dependent upon claim 1. Claim 1 claims:

[597]*597A modular prosthesis system comprising a prosthetic base portion having a surface for positioning adjacent to a corresponding bone, the base portion having a base mounting means thereon, and a stem extension for insertion into a cavity in a bone, the stem extension having a stem mounting means for mounting the stem extension to the base mounting means, and the stem extension further having an elongated stem portion connected to the stem mounting means by a connection portion, and wherein the stem mounting means has a first central longitudinal axis and the elongated stem portion has a second central longitudinal axis substantially parallel to the first axis, but which is spaced apart therefrom to provide an offset there-between.

’313 patent, col. 5, 11.17-30. The dependent claims add further limitations. For example, claim 2 requires a “radially adjustable” stem mounting means, id., col. 5, 1.32,1 and claim 3 requires the stem extension to be “releasably fixed to the base portion,” id., col. 5,1.37.2

In a decision dated April 3, 2003, the district court construed all of the asserted claims simultaneously. First, the court held that “[t]he ’313 patent requires that the stem extension be comprised of a single part.” Zimmer, 258 F.Supp.2d at 878. In addition, the district court construed the claims as follows:

The Court interprets these claims as follows: The ’313 patent describe[s] a prosthetic system with two primary components: a base and a stem extension. The base and stem each have mounting means that are designed to fit together in a variety of positions and orientations. This is important because the system can be adjusted radially, mid-surgery, to achieve the proper fit for each individual patient. The desired fit is achieved through the use of two longitudinal axes on the elongated stem portion of the stem extension. The axes are parallel but spaced apart to provide an offset for stability inside the bone. The base and stem are connected by a pin and recess. Moreover, the stem extension is “releaseably fixed” to the base, which permits the system to be further adjusted during surgery to achieve a proper fit for each patient.

Zimmer, 258 F.Supp.2d at 881 (citation omitted).

The court further held that the accused products did not literally infringe any of the ’313 patent claims (1) because they “lack an identical elongated stem extension” with an elongated stem and a connection portion on a single piece and (2) because they “utilize a permanent, threaded screw connection and interference fit to attach the base and stem extension that does not allow for radial adjustment,” unlike the adjustable Morse taper disclosed in the ’313 patent. Id. at 882 (emphasis in original). The district court also held that the accused products did not infringe under the doctrine of equivalents. First, the court held that the accused products’ “stem extension is not modular” because it, unlike the one-piece stem extension disclosed in the ’313 patent, “require[s] the assembly of three separate pieces ... for the stem extension portion to be operable.” [598]*598Id. at 883. Thus, according to the district court, “while the ’313 patent and the HOWMEDICA products provide the same outcome (stabilizing joints in the human body), there is a substantial difference between the products in the way this end is accomplished.” Id. at 884. In addition, the district court held that Zimmer’s argument that the Morse taper and threaded connections are equivalent “is discounted because the[ ]’313 patent does not disclose the use of an interference fit.” Id.

Zimmer timely appealed, and we have jurisdiction pursuant to 28 U.S.C. § 1295(a)(1).

DISCUSSION

“We review the district court’s claim construction and the grant of summary judgment based thereon without deference.” Novartis Pharms. Corp. v. Eon Labs Mfg., Inc., 363 F.3d 1306, 1308 (Fed.Cir.2004).

I

Judging from the confusing briefs filed by both parties in this court, the district court in this case confronted a difficult task in making sense out of the parties’ arguments. Apparently as a result of this party-generated confusion, the district court misunderstood the appropriate claim construction methodology in several respects.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gyrodata Inc. v. Gyro Technologies, Inc.
679 F. Supp. 2d 774 (S.D. Texas, 2009)
Zimmer Technology, Inc. v. Howmedica Osteonics Corp.
476 F. Supp. 2d 1024 (N.D. Indiana, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
111 F. App'x 593, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zimmer-inc-v-howmedica-osteonics-corp-cafc-2004.